News

HHS Systems Are in Danger of Collapsing, Workers Say
The purging of IT and cybersecurity staff at the Department of Health and Human Services could threaten the systems used by ...
The Heartland Institute1d
Congress Looks at Fast-Tracking Drugs, Devices Approved in Other Countries
The legislation would allow the FDA to approve drugs and devices that have already been approved in other industrialized ...
FDA Approves Bristol Myers Squibb's Opdivo Plus Yervoy to Treat Some Carcinomas
Bristol Myers Squibb said the Food and Drug Administration approved Opdivo plus Yervoy as a first-line treatment for certain types of carcinoma.
RFK Jr. Warns FDA Staff of ‘Deep State’ in All-Hands Meeting
Robert F. Kennedy Jr. warned Food and Drug Administration staff about the influence of the “deep state” on the agency in an ...
Recursion: FDA To Replace Animal Testing With AI? - A Small But Necessary Win
Recursion Pharmaceuticals' stock is soaring today on news the FDA is planning on phasing out some animal testing, replacing ...
Fierce Pharma3d
After Hetlioz’s rejection in jet lag disorder, Vanda sues FDA for right to promote off-label use
After years of back-and-forth with the FDA over Hetlioz's potential use as a jet lag disorder treatment, Vanda ...
Zacks Investment Research on MSN3d
Bayer Obtains Full FDA Approval for Oncology Drug Vitrakvi
Bayer BAYRY announced that the FDA has granted full approval to oncology drug, Vitrakvi (larotrectinib), a first-in-class TRK ...
National Law Review3d
District Court Strikes Down FDA’s LDT Rule, Opens the Door for Challenges to FDA’s Regulation of Other “Services” as Medical Devices
On Monday, March 31, a court in the Eastern District of Texas found unlawful and vacated the Food and Drug Administration’s ...
Why Recursion Pharmaceuticals Stock Is Skyrocketing Today
However, it's possible that other drugmakers could be more interested in teaming up with Recursion with the FDA promoting the ...
Verve Therapeutics wins FDA fast track status for cholesterol treatment
Verve Therapeutics (NASDAQ:VERV) stock gains as the company wins the FDA fast track designation for VERVE-102, a cholesterol ...
FDA move away from animals negative for Charles River, says JPMorgan
JPMorgan sees a likely negative impact to Charles River (CRL) after the FDA announced it would be reducing its animal testing requirements for ...
Charles River Labs Stock (CRL) Crashes 28% as FDA Signals End of Animal Testing Era
Shares of Charles River Labs (CRL) crashed 28% after the U.S. FDA (Food and Drug Administration) announced plans to phase out the need for ...